Skip to main content
Daniel Johnson, MD, Oncology, Houston, TX, Ochsner Medical Center

DanielJohnsonMD

Oncology Houston, TX

Hematology Oncology Fellow

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Johnson's full profile

Already have an account?

Education & Training

  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 2012
  • Louisiana State University
    Louisiana State UniversityFellowship, Medical Oncology
  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2020 - 2024
  • LA State Medical License
    LA State Medical License 2014 - 2024
  • MS State Medical License
    MS State Medical License 2019 - 2020
  • TX State Medical License
    TX State Medical License 2017 - 2020
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Interleukin-6 is potential target to de-couple checkpoint inhibitor-induced colitis from antitumor immunity. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
    NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)November 7th, 2018
  • Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meeting
    Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim MeetingNovember 14th, 2023

Hospital Affiliations